Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Sermorelin: Evidence Summary
Evidence summary for Sermorelin across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to Sermorelin overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| GH deficiency | Tier B | 12 | Well-established GH secretagogue with Phase II/III data |
| Anti-aging | Tier C | 4 | Limited controlled data for anti-aging indications |